Sat.Aug 24, 2024 - Fri.Aug 30, 2024

article thumbnail

Pharmacogenomics: The Up-and-Coming Field of Pharmacy

Pharmacy Is Right For Me

What is your first thought when you think of a career in pharmacy? You may think of a clinical pharmacist working in a community pharmacy or a hospital pharmacist working in an in-patient unit. But did you think about pharmacogenomics: the field of pharmacy that studies how someone’s genetics affect their response to a certain drug? Not many people are aware of the field of pharmacogenomics, and how it can optimize patient outcomes.

article thumbnail

Psilocybin Mushrooms: A Journey from Ancient Traditions to Modern Clinical Use

Drug Topics

As research continues to uncover the potential benefits of psilocybin, pharmacists and other clinicians have an essential role in bridging ancient wisdom with contemporary science.

232
232
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Efgartigimod Alfa Provides Much-Needed Treatment Options for Patients With Generalized Myasthenia Gravis

Pharmacy Times

Pharmacists can provide extra resources for patients, including explanations of the therapy options for the patients, the course of therapy, and what patients can expect.

149
149
article thumbnail

California, nation’s largest milk producer, discloses possible bird flu outbreaks in three dairy cow herds

STAT

On Thursday, the California Department of Food and Agriculture announced it is investigating the possible introduction of H5N1 bird flu in cattle at three dairy farms in the Central Valley. If confirmed, they would be the first known cases in that state. In a statement, officials said testing of samples from the three farms is currently underway in the state’s veterinary diagnostic lab.

145
145
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

The Importance of Reaching Out: Why Talking to Someone Matters

Pharmacy Is Right For Me

As the school year begins, students often find themselves juggling a variety of responsibilities—homework, extracurricular activities, social commitments, and more. For those with aspirations in the demanding field of pharmacy, the pressure to excel can sometimes feel overwhelming. During these moments, it’s essential to remember that you don’t have to navigate challenges alone.

article thumbnail

Free At-Home COVID-19 Test Program Returns as Cases Rise

Drug Topics

The government said the tests will “detect current COVID-19 variants and can be used through the end of the year.

203
203

More Trending

article thumbnail

STAT+: Wegovy cut patients’ chances of dying from Covid-19, new analysis shows

STAT

LONDON — Novo Nordisk made worldwide headlines last year when a study demonstrated that Wegovy, its powerful and exceedingly popular weight loss medicine, helped reduce the risk of cardiovascular emergencies like heart attacks.  Researchers on Friday unveiled results demonstrating another benefit that the drug offered to patients in that study: Compared to placebo, it cut the chances of dying from Covid-19 by roughly a third.

article thumbnail

Eli Lilly rolls out direct patient access to weight loss star Zepbound—at a deep discount

Fierce Pharma

Eli Lilly has come up with a new way of supplying its popular weight-loss drug Zepbound that the company hopes could expand access while addressing other issues such as high prices and off-label co | Eli Lilly is offering its popular weight-loss drug Zepbound directly to consumers at a discount through its own online pharmacy. The company hopes the move could expand access while addressing other issues such as high prices and off-label cosmetic usage.

Labelling 137
article thumbnail

High-Dose, Adjuvanted Flu Vaccines Prove More Effective for Older Adults

Drug Topics

“While seasonal variation exists, it is expected that seniors will continue to benefit from flu vaccines that are stronger than the traditional standard-dose vaccines,” wrote investigators.

Vaccines 168
article thumbnail

Patients With Asthma Experience Changes in Airway Inflammation Following Electronic Cigarette Use

Pharmacy Times

Using 1 nicotine-containing electronic cigarette was significantly correlated with an increase in residual volume and total lung capacity in patients with asthma.

139
139
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

STAT+: UnitedHealth pledged a hands-off approach after buying a Connecticut medical group. Then it upended how doctors practice

STAT

MIDDLETOWN, Conn. — UnitedHealth Group told the Connecticut primary care doctors everything they wanted to hear. Take our money, the company said, and together we can bring about a future where primary care leads. A future where doctors can take better care of their patients, and reap the financial rewards of improved health. We’ll handle the business side while you look after your patients.

145
145
article thumbnail

Recent moves by Epic, Carequality mark a major shift in interoperability, health IT experts say

Fierce Healthcare

Electronic health records giant Epic recently announced plans to transition its customers to a new government-backed data exchange by the end of next year. | Carequality and Epic both revealed plans to align with TEFCA, signaling potentially a "tectonic shift" in the interoperability landscape and the rising influence of the federal government's nascent network, health IT experts say.

134
134
article thumbnail

Dexcom’s OTC Continuous Glucose Monitor Now Available in US

Drug Topics

The Stelo glucose biosensor system is intended for use in adults who do not use insulin or in those without diabetes who wish to better understand how diet and exercise affect blood glucose levels.

154
154
article thumbnail

New ACIP Recommendations for RSV Vaccines Aim to Solve Challenges With Shared Clinical Decision-Making

Pharmacy Times

Shared clinical decision-making presented drawbacks, resulting in age-based recommendations for adults aged 75 years and older and risk-based recommendations for individuals aged 60-74 years.

Vaccines 131
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

21 cases of little-known Oropouche virus detected in U.S.

STAT

Nearly two dozen people in the United States have been confirmed to have contracted the Oropouche virus during travels outside the country this summer, the Centers for Disease Control and Prevention reported Tuesday. A previously little-known virus, Oropouche has garnered headlines in recent weeks with reports of a small number of deaths and a possible link to congenital malformations in babies infected in the womb.

145
145
article thumbnail

Feds killed plan to curb Medicare Advantage overbilling after industry opposition

Fierce Healthcare

A decade ago, federal officials drafted a plan to discourage Medicare Advantage health insurers from overcharging the government by billions of dollars—only to abruptly back off amid an “uproar” fr | Filings and testimonies in a multibillion-dollar Justice Department civil fraud case against UnitedHealth Group outline industry pressure that led the government to bury a proposed rule on Medicare Advantage chart reviews.

Insurance 131
article thumbnail

Q&A: Opill Ushers in New Era of Access to Birth Control

Drug Topics

Stephanie Sober, MD, MSHP, investigator on the pivotal research that supported the prescription-to-OTC switch of Opill, shares insights on how the medicine is reshaping the reproductive landscape.

123
123
article thumbnail

The Perfect Ingredient: Vaccine Education With Pharmacy Community Health Workers

Pharmacy Times

In Missouri, community health workers partnered with community pharmacists, CPESN, and others to develop a state-funded program to address vaccine gaps in local communities.

Vaccines 139
article thumbnail

Opinion: To stop mpox from becoming the next pandemic, we must address global vaccine inequities

STAT

In early 2022, I cared for one of the first patients with mpox in Massachusetts. As an infectious diseases physician, I remember the deep uncertainty I felt, and the fear in my patient’s eyes as a painful rash spread over their body. We were in uncharted territory — there were no proven treatments, and the number of cases was rapidly increasing.

Vaccines 142
article thumbnail

Merck’s Keytruda flunks pivotal studies in early-stage lung and skin cancers

Fierce Pharma

A Merck & Co. effort to move its PD-1 behemoth Keytruda into early treatment of lung cancer has reached a dead end, along with another bid to expand into a type of early-stage skin cancer. | A Merck & Co. effort to move its PD-1 behemoth Keytruda into early treatment of lung cancer has reached a dead end, along with another bid to expand into a type of early-stage skin cancer.

128
128
article thumbnail

FDA Approves Expanded Use of ACAM2000 Vaccine for Mpox Amid Public Health Emergency

Drug Topics

Emergent BioSolutions has announced that it will donate 50,000 doses of ACAM2000 for potential deployment across affected areas in Central Africa.

Vaccines 112
article thumbnail

Study: Children With First Dose of Measles Vaccine May Not Receive Both Globally

Pharmacy Times

Pharmacists can help facilitate more organized efforts to improve measles vaccination uptake for children aged 5 and younger by identifying socio-demographic gaps within this population.

Vaccines 126
article thumbnail

STAT+: Centene eliminates brokers’ commissions for Medicare drug plans

STAT

Health insurer Centene will not pay any commissions to brokers and agents who help people sign up for next year’s Medicare prescription drug plans. “We have made a difficult decision — effective Jan. 1, 2025 — to cease new and renewal commissions for [Medicare Part D plans] beginning with the 2025 plan year,” Centene’s WellCare subsidiary said last Friday in an email sent to brokers, which was obtained by STAT.

Insurance 139
article thumbnail

BioMarin cuts deeper with 225 layoffs under CEO's new corporate strategy

Fierce Pharma

The rightsizing at BioMarin continues to take its toll as CEO Alexander Hardy devises a new corporate strategy for the rare disease biotech. | The rightsizing at BioMarin continues to take its toll as CEO Alexander Hardy devises a new corporate strategy for the rare disease biotech.

128
128
article thumbnail

After an FDA rejection, here’s what’s next in the psychedelics pipeline

PharmaVoice

By rejecting the first MDMA therapy earlier this month, the FDA signaled to the psychedelic drug sector that the road to approval isn’t clear cut.

FDA 134
article thumbnail

Distinguishing Between Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome

Pharmacy Times

Although small intestinal bacterial overgrowth (SIBO) and irritable bowel syndrome (IBS) share many of the same symptoms, SIBO affects the small intestine and IBS affects the large intestine.

123
123
article thumbnail

STAT+: To help migraine patients — and sell more medicines — major drugmakers turn to telehealth

STAT

In 2021, Katey Frederking had reached the end of her rope. The 29-year-old was struggling with frequent migraines, which started after a concussion from a fall on an icy patch near her home in Chicago. The medications she had been prescribed weren’t working, her doctor wasn’t listening, and she was facing several months of wait time before she could see a new neurologist.

142
142
article thumbnail

Emergent's smallpox vaccine picks up FDA nod for mpox as Africa outbreak spreads

Fierce Pharma

As a new deadly strain of mpox continues its global spread, Emergent BioSoultion's smallpox vaccine ACAM2000 has officially joined the ranks of FDA-approved defense measures against the virus. | With the nod, Emergent's vaccine joins Bavarian Nordic's Jynneos as approved protection options to address the continued outbreak in Africa, which was recently deemed a public health emergency.

Vaccines 122
article thumbnail

Rep. Comer threatens PBM execs with fines, jail time over 'fraudulent' hearing testimony

Fierce Healthcare

A key legislator is accusing the leaders of the three largest pharmacy benefit managers of making fraudulent statements during a hearing last month on the industry. | A key legislator is accusing the leaders of the three largest pharmacy benefit managers of making fraudulent statements during a hearing last month on the industry.

122
122
article thumbnail

Nipocalimab Data Submitted for FDA Approval in Generalized Myasthenia Gravis

Pharmacy Times

The application includes data from the Vivacity-MG3 study, demonstrating that individuals who received the drug had superior outcomes compared with the standard of care alone.

FDA 121
article thumbnail

STAT+: Lilly launches Zepbound vials in move that could ease supply constraints

STAT

Eli Lilly said Tuesday that it will start providing low-dose vials of its obesity drug Zepbound through its direct-to-consumer platform, a move that will likely ease supply constraints and draw more patients to the company’s online portal. Lilly is also selling the vials at a discount to the currently available injectable pens, which carry a list price of $1,060 for a month’s supply.

Dosage 141
article thumbnail

SCOTUS overturn of Chevron doctrine opens a Pandora's box for biopharma industry, expert says

Fierce Pharma

For the last 40 years, when federal legislation was ambiguous or left an administrative gap, courts were required to defer to the interpretation of federal agencies. | In June, when the Supreme Court voted 6-3 to overturn the Chevron doctrine, it brought significant impact for the healthcare industry and federal regulators like the FDA and the Centers for Medicare & Medicaid Services.

FDA 124
article thumbnail

School Openings After COVID-19 Lockdowns Associated with Increased Psychiatric Emergencies

Drug Topics

Researchers addressed the association of COVID-19 pandemic-related school disruptions with children’s incidence of acute psychiatric emergencies.

112
112
article thumbnail

Congress Requests Corrections to Testimony From Three Largest Pharmacy Benefit Manager Executives Following FTC Report

Pharmacy Times

The request comes as increased scrutiny is levied toward pharmacy benefit managers for alleged unfair business practices.

147
147